TrialBritish journal of cancer2017

Discrepancies in central review re-testing of patients with ER-positive and HER2-negative breast cancer in the OPTIMA prelim randomised clinical trial.

S E Pinder et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.